134 related articles for article (PubMed ID: 10037445)
41. New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme.
Sharma RK; Douglas RG; Louw S; Chibale K; Sturrock ED
Biol Chem; 2012 May; 393(6):485-93. PubMed ID: 22628311
[TBL] [Abstract][Full Text] [Related]
42. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380.
Corradi HR; Chitapi I; Sewell BT; Georgiadis D; Dive V; Sturrock ED; Acharya KR
Biochemistry; 2007 May; 46(18):5473-8. PubMed ID: 17439247
[TBL] [Abstract][Full Text] [Related]
43. Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).
Inokuchi J; Nagamatsu A
Biochim Biophys Acta; 1981 Dec; 662(2):300-7. PubMed ID: 6274413
[TBL] [Abstract][Full Text] [Related]
44. Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors.
Douglas RG; Sharma RK; Masuyer G; Lubbe L; Zamora I; Acharya KR; Chibale K; Sturrock ED
Clin Sci (Lond); 2014 Feb; 126(4):305-13. PubMed ID: 24015848
[TBL] [Abstract][Full Text] [Related]
45. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanism of the interactions between inhibitory tripeptides and angiotensin-converting enzyme.
Zhou M; Du K; Ji P; Feng W
Biophys Chem; 2012 Jul; 168-169():60-6. PubMed ID: 22835627
[TBL] [Abstract][Full Text] [Related]
47. Structure based drug design of angiotensin-I converting enzyme inhibitors.
Anthony CS; Masuyer G; Sturrock ED; Acharya KR
Curr Med Chem; 2012; 19(6):845-55. PubMed ID: 22214449
[TBL] [Abstract][Full Text] [Related]
48. [Angiotensin converting enzyme domain structure and properties].
Kugaevskaia EV
Biomed Khim; 2005; 51(6):567-80. PubMed ID: 16521820
[TBL] [Abstract][Full Text] [Related]
49. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
[TBL] [Abstract][Full Text] [Related]
50. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236
[TBL] [Abstract][Full Text] [Related]
51. Angiotensin-converting enzyme: I. New strategies for assay.
Ryan JW; Chung A; Ryan US
Environ Health Perspect; 1980 Apr; 35():165-70. PubMed ID: 6250809
[TBL] [Abstract][Full Text] [Related]
52. The tetrapeptide N-acetyl-seryl-aspartyl-lysl-proline and angiotensin-converting enzyme.
Luft FC
J Mol Med (Berl); 2002 Aug; 80(8):461-2. PubMed ID: 12418489
[No Abstract] [Full Text] [Related]
53. A novel peptide-processing activity of insect peptidyl-dipeptidase A (angiotensin I-converting enzyme): the hydrolysis of lysyl-arginine and arginyl-arginine from the C-terminus of an insect prohormone peptide.
Isaac R; Schoofs L; Williams TA; Veelaert D; Sajid M; Corvol P; Coates D
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):61-5. PubMed ID: 9461491
[TBL] [Abstract][Full Text] [Related]
54. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.
Ehlers MR; Schwager SL; Scholle RR; Manji GA; Brandt WF; Riordan JF
Biochemistry; 1996 Jul; 35(29):9549-59. PubMed ID: 8755736
[TBL] [Abstract][Full Text] [Related]
55. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
56. Development of domain-selective angiotensin I-converting enzyme inhibitors.
Redelinghuys P; Nchinda AT; Sturrock ED
Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
[TBL] [Abstract][Full Text] [Related]
57. Structure-function studies of BPP-BrachyNH
Arcanjo DDR; Vasconcelos AG; Nascimento LA; Mafud AC; Plácido A; Alves MMM; Delerue-Matos C; Bemquerer MP; Vale N; Gomes P; Oliveira EB; Lima FCA; Mascarenhas YP; Carvalho FAA; Simonsen U; Ramos RM; Leite JRSA
Eur J Med Chem; 2017 Oct; 139():401-411. PubMed ID: 28810191
[TBL] [Abstract][Full Text] [Related]
58. Molecular basis of exopeptidase activity in the C-terminal domain of human angiotensin I-converting enzyme: insights into the origins of its exopeptidase activity.
Naqvi N; Liu K; Graham RM; Husain A
J Biol Chem; 2005 Feb; 280(8):6669-75. PubMed ID: 15615692
[TBL] [Abstract][Full Text] [Related]
59. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]